Showing results (811-820 of 5,930) with videos related to
Sort By:
Pageof 593
The Prostate|July 6, 2000
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathwaysA Plonowski, A V Schally, J L Varga, et al.The Prostate|July 4, 2001
Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosinK Keledjian, A Borkowski, G Kim, et al.The Prostate|July 4, 2001
Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancerL M Chen, G B Hodge, L A Guarda, et al.The Prostate|July 4, 2001
Calcium, dairy products, and the risk of prostate cancerA Tavani, S Gallus, S Franceschi, et al.The Prostate|July 4, 2001
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessingS R Denmeade, J Lövgren, S R Khan, et al.The Prostate|September 6, 2001
Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cellsM Burchardt, T Burchardt, A Shabsigh, et al.The Prostate|April 17, 2001
Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cellsL Wang, B Liu, M Schmidt, et al.The Prostate|April 17, 2001
Androgen receptor expression in androgen-independent prostate cancer cell linesA Chlenski, K Nakashiro, K V Ketels, et al.The Prostate|March 10, 2001
Voltage-gated K(+) channel activity in human prostate cancer cell lines of markedly different metastatic potential: distinguishing characteristics of PC-3 and LNCaP cellsM E Laniado, S P Fraser, M B DjamgozThe Prostate|March 10, 2001
Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic featuresN Engedal, F SaatciogluPageof 593